CELLFUSE
LIVE

Serial Number

88245691

Owner

Regenacell Therapy, Inc.

Attorney

Arvid von Taube

First Use Date

Aug 1, 2019

Filing Date

Dec 31, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CELLFUSE Trademark

Serial Number: 88245691 • Registration: 6120774

CELLFUSE is a trademark filed by Regenacell Therapy, Inc. on December 31, 2018. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Regenacell Therapy, Inc. (4 trademarks)

2328 Saddleback Drive
Castle Rock, CO 80104

Entity Type: 03

STEM GENIX SOLUTIONS LLC

PO BOX 544
CENTER VALLEY, PA 18034

Entity Type: 16

Trademark Details

Filing Date

December 31, 2018

Registration Date

August 4, 2020

First Use Anywhere

August 1, 2019

First Use in Commerce

October 1, 2019

Goods & Services

Medical devices, namely, devices to aspirate bone marrow and harvest autologous bone dowels; synthetic bone graft substitute materials; medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site; medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow and harvest autologous bone dowels, synthetic bone graft substitute materials, and medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 4, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 20, 2024 ASGN
REGISTERED-SUPPLEMENTAL REGISTER
Aug 4, 2020 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 1, 2020 PREV
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jun 25, 2020 AAUA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jun 24, 2020 CNTA
USE AMENDMENT ACCEPTED
Jun 24, 2020 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Jun 3, 2020 AUPC
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2020 CRFA
ASSIGNED TO LIE
Mar 16, 2020 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 9, 2020 ERFR
USE AMENDMENT FILED
Mar 6, 2020 IUAF
TEAS AMENDMENT OF USE RECEIVED
Mar 6, 2020 EAAU
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 11, 2019 GNFN
FINAL REFUSAL E-MAILED
Sep 11, 2019 GNFR
FINAL REFUSAL WRITTEN
Sep 11, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 25, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 25, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 25, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2019 NWOS
NEW APPLICATION ENTERED
Jan 3, 2019 NWAP